Researchers from the RCSI University of Medicine and Health Sciences have developed a new 3D implant solution that helps heal spinal cord injuries. Their study, published in the journal Bioactive ...

Researchers show how LGP2 binds viral RNA ends, moves along the strand, and helps MDA5 form filaments that amplify antiviral ...

Sarepta Therapeutics receives a revised brokerage price outlook, drawing market attention toward the rare disease biotechnology segment. Institutional capital repositioning across biotechnology ...

Hidden in volcanic lakes and deep-sea vents, scientists have discovered tough new DNA-binding proteins built to survive extreme conditions. After scanning huge genetic databases, researchers found ...

Scientists have developed Evo 2, a powerful AI model that can analyze and generate DNA sequences across all domains of life.

A recent study utilizing cryo-EM advances our understanding of how bacterial immune systems function and reveals new aspects ...

Dyne Therapeutics (NasdaqGS:DYN) has initiated the Phase 3 Harmonia trial of DYNE-101 in myotonic dystrophy type 1, following alignment with the FDA on the study design. The Harmonia trial is a ...

I was born in Washington, DC, in 1964, the oldest of three sisters, but the place that truly formed me as a scientist was Hilo, on the Big Island of Hawaii. Growing up there, far from the mainland ...

All complex biological systems—like the DNA, RNA and proteins constantly being copied and built within our cells—are prone to errors. That means as life evolved to be more elaborate, it also had to ...

Pelvic organ prolapse (POP) represents a highly prevalent condition among women, particularly following childbirth and during aging, with recurrence rates following surgical intervention posing ...

A pre-clinical biopharmaceutical company dedicated to precision cardiology through targeted RNA therapeutics designed to ...